Article info

Download PDFPDF
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery

Authors

  1. Correspondence to Dr Josephine S Kim, Section of Gynecologic Oncology, University of Chicago Medicine, Chicago, IL 60637, USA; josephine.kim{at}gmail.com
View Full Text

Citation

Kim JS, Liang MI, Prendergast EN, et al
Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery

Publication history

  • Received February 25, 2019
  • Revision received May 22, 2019
  • Accepted May 24, 2019
  • First published July 27, 2019.
Online issue publication 
September 01, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.